Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months

Christopher Straka, D. W Nathan Kim, Robert D. Timmerman, Ivan Pedrosa, Corbin Jacobs, James Brugarolas

Research output: Contribution to journalArticlepeer-review

21 Scopus citations
Original languageEnglish (US)
Pages (from-to)e401-e403
JournalJournal of Clinical Oncology
Volume31
Issue number23
DOIs
StatePublished - Aug 10 2013

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this